>  Presse  >  Communiqués de presse  >  A l'International  >  Washington / Conférence internationale sur le sida - Figh...

Communiqué de presse

Washington Call for access to HCV diagnostics, treatment and care for all!

Over the last decade, HIV drug prices have dropped dramatically, and access to antiretroviral therapy has significantly increased. It is time to apply the lessons from HIV/AIDS to hepatitis C virus (HCV).

Over the last decade, HIV drug prices have dropped dramatically, and access to antiretroviral therapy has significantly increased. It is time to apply the lessons from HIV/AIDS to hepatitis C virus (HCV). An estimated 170 million people have chronic hepatitis C. At least 350,000 of them die from it each year although it is curable. Access to prevention tools, diagnostics, and treatment remains extremely limited, particularly for people who inject drugs, a group disproportionately affected by HCV. Few people in the Global South have access, even those living with HIV/AIDS.
Therefore, on the occasion of the XIX International Aids Conference in Washington, DC, USA, and the eve of World Hepatitis Day, the undersigned grassroots civil society groups and non-governmental organizations have formed an international coalition working towards universal access to HCV voluntary testing and treatment.

We call upon:

  • The pharmaceutical companies - particularly Roche & Merck - to drastically reduce the price of diagnostics and treatment regimens for the estimated 170 million individuals suffering from chronic hepatitis C, particularly those with HIV co-infection.
  • Political leaders to mobilize the adequate resources needed now and in the future--in anticipation of new HCV drugs--- to diagnose, monitor and treat high-prevalence populations, such as people living with HIV/AIDS and people who inject drugs.  
  • The World Health Organization (WHO) and other relevant United Nations (UN) agencies to develop treatment guidelines for HCV treatment for HIV/HCV co-infected people and HCV mono-infected persons in low and middle income countries and to develop a prequalification process for bio-similars that facilitates access to pegylated interferon.
  • Researchers to gather and provide evidence on feasibility and effectiveness of treatment in low and middle income countries, with a focus on disproportionately affected populations, particularly people who inject drugs.
  • International donors to support community mobilization and treatment preparedness and literacy, as well as treatment cost, which are crucial for access to treatment.


Treatment saves life

Access for all!


To support the Washington Call on behalf of your organization, please send us your signature by email at chloe.forette@medecinsdumonde.net


Signatories:

Act Up-Basel, Switzerland

Act Up-Paris, France

Afghan Drug Users Group (ADUG), Afghanistan

African Services Committee, USA

AIDES, France

AIDS Action Baltimore, USA

AIDS Foundation of Chicago, USA

Andrey Rylkov Foundation for Health and Social Justice - Moscow, Russia

Asia Catalyst

Asian Network of People who Use Drugs (ANPUD)

Asia Pacific Network of Positive People (APN+)

Association de lutte contre le sida (ALCS), Morocco

Association Française pour la Réduction des Risques (AFR), France

AutoSupport des Usagers de Drogues (ASUD), France

Baltimore Student Harm Reduction Coalition, USA

BC Centre for Excellence in HIV/AIDS, Canada

Canadian Drug Policy Coalition, Canada

Coalicion Internacional de Activistas en Tratamiento (CIAT)

Coalition Internationale PLUS

Delhi Network of People Living with HIV (DNP+), India

E.V.A. – Russia

Empower India, India

European AIDS Treatment Group (Eatg)

Gaïa Paris, France

Georgian Harm Reduction Network, Georgia

Harm Reduction Coalition, USA

Harm Reduction International (HRI)

HIV Prevention Justice Alliance (HIV PJA)

Initiative for Medicines, Access & Knowledge (I-MAK), USA

International Centre for Science in Drug Policy

International Network of People Using Drugs (INPUD)

ITPC Eastern Europe and Central Asia

ITPC North Africa

Mainline, Netherlands

Malaysian AIDS Council, Malaysia

Maryland Hepatitis Coalition, USA

Médecins du Monde, France

Mouvement contre le racisme et pour l'amitié entre les peuples (MRAP), France

National Association of people living with HIV/AIDS in Nepal (NAP+N), Nepal

Nava Kiran Plus, Nepal

Open Society Foundations, Public Health Program

Pan African Positive Women's Coalition, Zimbabwe

Pinoy Plus Association Inc, Philippines

Prévention Information Lutte contre le Sida (PILS), Mauritius

Red Bolivianas de Personas con VIH de Bolivia (REDBOL), Bolivia

Sidaction, France

Solidarité Thérapeutique et Initiatives contre le sida (Solthis), France

Thai AIDS Treatment Action Group (TTAG), Thailand

The Hepatitis C Mentor and Support Group, Inc., USA

Treatment Action Group (TAG), USA

Women and Harm Reduction International Network (WHRIN)